Evidence map›Paper›PMID 20805374›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2011

Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent.

Huandong Yan, Deepak A Deshpande, Anna M Misior, Matthew C Miles, Himansh Saxena, Ellen C Riemer, Rodolfo M Pascual, Reynold A Panettieri, Raymond B Penn

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 66 citations in OpenAlex.

  1. Agonist-specific conformational dynamics at the βBritish journal of pharmacology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Cooperativity between β-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  13. Can GPCRs Be Targeted to Control Inflammation in Asthma?Advances in experimental medicine and biology · 2021
    Article
  14. Role of Airway Smooth Muscle in Inflammation Related to Asthma and COPD.Advances in experimental medicine and biology · 2021
    Article
  15. Review
  16. Review
  17. Effect of Adenylyl Cyclase Type 6 on Localized Production of cAMP byThe Journal of pharmacology and experimental therapeutics · 2019
    Article
  18. Regulation of ovarian cancer G protein-coupled receptor-1 expression and signaling.American journal of physiology. Lung cellular and molecular physiology · 2019
    Article
  19. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Huandong YanDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201-1075, USA.
Deepak A Deshpande
Anna M Misior
Matthew C Miles
Himansh Saxena
Ellen C Riemer
Rodolfo M Pascual
Reynold A Panettieri
Raymond B Penn
University of Maryland, Baltimore · USWake Forest University · USMedical University of South Carolina · USUniversity of Pennsylvania · US

Funding

Interdisciplinary Training Program Muscle BiologyT32AR007592 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Aikaterini Kontrogianni-Konstantopoulos · 1996 to 2026
$11.7M
G Protein-Coupled Receptor Signaling in Airway Smooth MuR01HL058506 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RAYMOND B. PENN · 2001 to 2026
$9.3M
Molecular basis of age-dependent changes in airway smooth muscle functionsR01AG041265 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI DESHPANDE, DEEPAK A · 2012 to 2016
$1.7M
Molecular Mechanisms of Airway Smooth Muscle RelaxationR00HL087560 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI DESHPANDE, DEEPAK A · 2009 to 2011
$747k
Molecular Mechanisms of Airway Smooth Muscle RelaxationK99HL087560 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DESHPANDE, DEEPAK A · 2007 to 2008
$172k
BETA ADRENERGIC RECEPTOR REGULATION IN HUMAN AIRWAY MUSCR29HL058506 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI PENN, RAYMOND B. · 1997 to 2000
$113k
NHLBI NIH HHS HL087560NHLBI NIH HHS HL58506NHLBI NIH HHS K99 HL087560NHLBI NIH HHS R00 HL087560NHLBI NIH HHS R01 HL058506NHLBI NIH HHS R29 HL058506NIAMS NIH HHS AR007592NIAMS NIH HHS T32 AR007592NIA NIH HHS R01 AG041265
6 · The paper itself

Abstract

Inhaled β-agonists are effective airway smooth muscle (ASM)-relaxing agents that help reverse bronchoconstriction in asthma, but their ability to affect the aberrant ASM growth that also occurs with asthma is poorly understood. β-Agonists exhibit PKA-dependent antimitogenic effects in several cell types. However, recent studies suggest that Epac, and not PKA, mediates the antimitogenic effect of cAMP in both ASM and fibroblasts. This study aims to clarify the role of PKA in mediating the effect of G(s)-coupled receptors on human ASM growth. Pretreatment of ASM cultures with β-agonists albuterol, isoproterenol, or salmeterol (100 nM to 10 μM) caused a significant (∼ 25-30%) inhibition of EGF-stimulated ASM thymidine incorporation and cell proliferation, whereas a much greater inhibition was observed from pretreatment with PGE(2) (75-80%). However, all agents were ineffective in cells expressing GFP chimeras of either PKI (a PKA inhibitor) or a mutant PKA regulatory subunit relative to the control cells expressing GFP. The antimitogenic efficacy of PGE(2) in inhibiting control cultures was associated with greater ability to stimulate sustained PKA activation and greater inhibition of late-phase promitogenic p42/p44 and PI3K activities. These findings suggest that therapeutic approaches enabling superior PKA activation in ASM will be most efficacious in deterring ASM growth.

Indexed as

Adaptor Proteins, Signal TransducingAdrenergic beta-2 Receptor AgonistsAlbuterolBronchodilator AgentsCell ProliferationCells, CulturedCyclic AMP-Dependent Protein KinasesDinoprostoneEnzyme ActivationEpidermal Growth FactorGreen Fluorescent ProteinsHumansImmunoblottingIntracellular Signaling Peptides and ProteinsIsoproterenolMitogen-Activated Protein Kinase 1Adaptor Proteins, Signal TransducingAdrenergic beta-2 Receptor AgonistsAlbuterolBronchodilator AgentsCyclic AMP-Dependent Protein KinasesDinoprostoneEpidermal Growth FactorGreen Fluorescent ProteinsIntracellular Signaling Peptides and ProteinsIsoproterenolMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Phosphatidylinositol 3-KinasesPKIA protein, humanSalmeterol Xinafoate

Identifiers

PMID20805374
PMCPMC3005432
OpenAlexW2094271757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.